Mycota powder

देश: यूनाइटेड किंगडम

भाषा: अंग्रेज़ी

स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)

सक्रिय संघटक:

Zinc undecenoate; Undecenoic acid

थमां उपलब्ध:

Thornton & Ross Ltd

ए.टी.सी कोड:

D01AE20

INN (इंटरनेशनल नाम):

Zinc undecenoate; Undecenoic acid

डोज़:

200mg/1gram ; 20mg/1gram

फार्मास्यूटिकल फॉर्म:

Cutaneous powder

प्रशासन का मार्ग:

Cutaneous

वर्ग:

No Controlled Drug Status

प्रिस्क्रिप्शन प्रकार:

Valid as a prescribable product

उत्पाद समीक्षा:

BNF: 13100200; GTIN: 5011309893113

सूचना पत्रक

MYCOTA POWDER

उत्पाद विशेषताएं

OBJECT 1
MYCOTA POWDER
Summary of Product Characteristics Updated 21-Oct-2020 | Thornton &
Ross Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Mycota Powder
2. Qualitative and quantitative composition
Quantity/dose unit or % quantity
Zinc Undecylenate Ph.Eur 20.00 %w/w
Undecylenic Acid Ph.Eur 2.00 %w/w
Excipients(s) with known effect:
Perfume Compound 11899 Narom (Contains Euganol) 0.143 % w/w
For full list of excipients, see section 6.1
3. Pharmaceutical form
Cutaneous powder.
A cream coloured powder free from lumps; perfumed.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment and prevention of athlete's foot.
4.2 Posology and method of administration
Route of administration: Cutaneous
Treatment
Each night and morning wash and thoroughly dry the affected parts and
sprinkle on Mycota Powder
(preferably after applying Mycota Cream or Spray to the area). Ensure
a generous application between the
toes and each day wear clean socks or stockings dusted inside wit